Our recent study and increasing evidence have shown that the dysregulation of RNA-related N6-methyladenosine (m6A) effectors, including methyltransferases, demethylases, and m6A-binding proteins, is pivotal in BC pathogenesis [7, 8]. This evidence concerns the gene MBD2 and breast cancer.